Area of research
Aerospace Engineering · Geriatrics and Gerontology
Research interest
Research interests include Medicine, Geriatric oncology, Multidisciplinary approach, Oncology, Internal medicine, and Cancer.
The CSF-1R inhibitor pexidartinib affects FLT3-dependent DC differentiation and may antagonize durvalumab effect in patients with advanced cancers
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
MEDIPLEX: A phase 1 study of durvalumab (D) combined with pexidartinib (P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC).
Multidisciplinary development of the Geriatric Core Dataset for clinical research in older patients with cancer: A French initiative with international survey
Role of geriatric intervention in the treatment of older patients with cancer: rationale and design of a phase III multicenter trial
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA)
Integrated oncogeriatric approach: a systematic review of the literature using concept analysis